DJIA 17,273.99 82.62 0.48%
NASDAQ 4,628.57 -9.43 -0.20%
S&P 500 2,003.48 1.32 0.07%
market minute promo

company name or ticker
Company Photos
(Click to zoom)

Bristol-Myers Squibb Names Caforio CEO, Andreotti To Become Chairman

Feeling Good With This Med Company

Investing in the Next Apple: 4 Boring But Innovative Companies to Buy Now

Could This Common Medicine Cabinet Supplement Be the Key to Increased Survival for Some Cancer Patie

Is it really this simple? Could this medicine cabinet supplement really improve the average survival of advanced cancer patients? A new study might suggest so.

How To Play Gilead In 2015: It's Going To Be A Bumpy Ride

Jim Cramer on Europe and Why He's an 'America First' Stock Picker

Bristol-Myers' Opdivo - The New Cash Cow

AbbVie Inc.'s Insights at the JP Morgan Healthcare Conference

AbbVie highlighted its hepatitis C and oncology growth opportunities at the annual JP Morgan Healthcare Conference.

Can You Guess Which Big Pharma Has a More Robust Pipeline Than Pfizer, Inc.?

Pfizer's pipeline currently features 86 clinical studies and/or registrations. That's an incredible figure that demonstrates Pfizer's commitment to R&D. But, it's also not the most robust pipeline in the pharmaceutical sector. Can you guess which big pharma company has an even larger pipeline than Pfizer?

Eli Lilly Inks Oncology Deals with Merck, Bristol-Myers - Analyst Blog

See More Articles...